Use of medications of questionable benefit in advanced dementia. - sprookjes - yvandenbroek - TriplyDB

Use of medications of questionable benefit in advanced dementia.

Use of medications of questionable benefit in advanced dementia.

http://www.wikidata.org/entity/Q36398853

about

Recent Literature on Medication Errors and Adverse Drug Events in Older Adults A systematic review of the emerging deﬁnition of 'deprescribing' with network analysis: implications for future research and clinical practice CLINICAL PRACTICE. Advanced Dementia Where Words Fail, Music Speaks: A Mixed Method Study of an Evidence-Based Music Protocol.The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Assessing medication burden and polypharmacy: finding the perfect measure Antihypertensive withdrawal for the prevention of cognitive decline.Potentially suboptimal prescribing for older veteran nursing home patients with dementia.'I don't think I'd be frightened if the statins went': a phenomenological qualitative study exploring medicines use in palliative care patients, carers and healthcare professionals.Systems to identify potentially inappropriate prescribing in people with advanced dementia: a systematic review.Determinants of Potentially Inappropriate Medication Use in Long-Term and Acute Care Settings: A Systematic Review.Medication appropriateness for patients with dementia approaching the end of their life.Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia.Deprescription in Advanced Cancer Patients Referred to Palliative Care.Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.Towards defining restlessness in individuals with dementia.Development and application of medication appropriateness indicators for persons with advanced dementia: a feasibility study.Advanced Dementia.Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis.Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.Withdrawal of Antidementia Drugs in Older People: Who, When and How?A population-level study examining discontinuation of statins in older people with dementia.The epidemiology of polypharmacy in older adults: register-based prospective cohort study.STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation.

P2860

Q26775182-0DEDE8EF-5843-4532-BC6C-B85EB3809734 Q28078344-E89E2AB1-D165-4BDF-A224-DCAC0ED0700E Q28082593-96C7F935-FB56-41D0-93A3-B50ED5D69CD3 Q30386936-7CD95636-3A1D-4EBC-AB92-F757B867EC3D Q33165801-D5426272-1745-438E-B98B-5CFF3CC7AEFE Q33814172-C9E6C77F-BD8D-439F-BF3C-908CDBFE671D Q34543877-7A02130F-57D4-41C9-98B5-CDCFD7E5C025 Q34747234-65761CEB-27A8-4C69-B541-596C289B4A64 Q35907831-3A2C2FEA-2F9E-4B22-8137-8EC7CF62B08D Q36035333-56D5AC09-A8FF-42A8-8025-EC03B45D41FB Q38648289-9306C892-3577-4B0D-AD2C-C98E3AF7F5AE Q38823681-2390DC59-99D7-473D-AC1A-BA41CE51617E Q38859941-8F8CBA83-9D39-4185-B1C1-1353B721F773 Q38918619-4D8D011A-A91E-40C1-B62A-87DE0310C89D Q39657233-1F655825-16EE-4542-8067-1C4679B78B19 Q40131312-57F176BB-0C78-4C5C-A5F5-819D49B9D983 Q41722511-A8663C03-EAAF-4925-B7E4-D579852F59D9 Q42855445-FEF19909-5D54-42F5-BD90-FC596D1AE1F9 Q47095007-AA279FE0-6B51-4712-99B1-2D3973086A1D Q47763564-73F4034C-2C16-4A38-9BF1-C0A024469C04 Q48167336-B522FFE9-C6BF-4170-9910-37131209E8B9 Q49384525-197C4424-BBE0-4614-ACC9-FC11BD4833B3 Q51761139-544EF62A-3054-46EF-AEFE-85BB36EE6171 Q53550622-E708306C-70EB-4B56-9051-FAA1637F4AB4

P2860

Use of medications of questionable benefit in advanced dementia.

http://www.wikidata.org/entity/Q36398853

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Use of medications of questionable benefit in advanced dementia.

@ast

Use of medications of questionable benefit in advanced dementia.

@en

type

label

Use of medications of questionable benefit in advanced dementia.

@ast

Use of medications of questionable benefit in advanced dementia.

@en

prefLabel

Use of medications of questionable benefit in advanced dementia.

@ast

Use of medications of questionable benefit in advanced dementia.

@en

P1433

Q36398853-A49CF7E1-67BE-40AE-AD59-C65A8344C80D

P1476

Q36398853-17F66577-1B30-4E2F-A70A-820B27728A33

P2093

Q36398853-3F7C2078-7664-4FB4-80F7-F1D822AE2B18

Q36398853-6D2E76F3-E89F-4E6B-AE29-752DC447C32C

Q36398853-6FEE3711-F11E-4B9C-9778-BC752B55B9CB

Q36398853-C85DAB6A-158E-4A4B-A5F3-E488CFED2FD2

Q36398853-DF9FD1E3-C81C-46BE-8940-249CED868287

Q36398853-FFAFE576-4AAF-44DE-8C4B-BE79A76244FA

P2860

Q36398853-0100C9DD-8928-4C1F-8146-AA43D83C07DF

Q36398853-04582AC7-04B3-49D3-A9D1-67CF467D616D

Q36398853-1A072A68-4022-4AC9-84F1-871B4063A06C

Q36398853-1BA0180C-756A-4A06-8764-70DEE3C2A768

Q36398853-28F86B31-42BB-46B8-8690-FD86E596E7B9

Q36398853-29BCD89E-A03E-4B28-B43A-172FC2E982E7

Q36398853-2E644FD2-BFDB-435E-8952-9B0222FF554A

Q36398853-324903A0-EBEC-4F2B-BF11-0C5F9FD9304A

Q36398853-32B3015A-5FDD-4D93-AF18-FB339387C0A7

Q36398853-3A46B3B0-ABEF-4199-B42F-4A94E5424771

P304

Q36398853-D4AA5EEC-AFED-43EE-99C7-EEDBF595FFBF

P31

Q36398853-16A52FDD-2295-484A-AA12-D559B762A9BD

P356

Q36398853-87673127-999C-4909-AC0C-DC095985E7F9

P433

Q36398853-15948D82-6117-49EA-8C20-0E408125A994

P478

Q36398853-8D31A564-EF97-44A3-88EE-9EFAEDA8406F

P577

Q36398853-B5ED7F63-2839-41CB-9614-D5B67E67DBC8

P5875

Q36398853-62B41EC5-3379-4D8F-B570-D64055D0D085

P698

Q36398853-E1800324-B56F-4208-AB44-698A193B0D09

P921

Q36398853-17E3D22D-C830-4A74-9EAB-D6F8A2E9D405

P932

Q36398853-583B1042-220D-47B1-9AB8-9AF6D9519C11

P356

JAMAINTERNMED.2014.4103

P1433

JAMA Internal Medicine

P1476

Use of medications of questionable benefit in advanced dementia.

@en

P2093

Becky A Briesacher

http://www.w3.org/2001/XMLSchema#string

Daniel Peterson

http://www.w3.org/2001/XMLSchema#string

Jennifer Tjia

http://www.w3.org/2001/XMLSchema#string

Qin Liu

http://www.w3.org/2001/XMLSchema#string

Susan E Andrade

http://www.w3.org/2001/XMLSchema#string

Susan L Mitchell

http://www.w3.org/2001/XMLSchema#string

P2860

American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults

The clinical course of advanced dementia

Cost-effectiveness of drug therapies for Alzheimer's disease: A brief review.

Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature.

A comprehensive clinical assessment tool to inform policy and practice: applications of the minimum data set.

Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.

Antipsychotic use among nursing home residents

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.

Daily medication use in nursing home residents with advanced dementia.

P304

1763-1771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAINTERNMED.2014.4103

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265475120

http://www.w3.org/2001/XMLSchema#string

P698

25201279

http://www.w3.org/2001/XMLSchema#string

P921

P932

4689196

http://www.w3.org/2001/XMLSchema#string